Skip to content
Events
rna seq graphic

Details

This webinar will provide a comprehensive overview of RNA sequencing. It is part 1 of a 3-part series and it is designed to help both new and experienced users understand Illumina’s streamlined RNAseq workflow from RNA isolation to sequencing, focusing on library prep kit options, sequencing requirements and output guidelines.

Webinar Date:   30th July 2025,Wednesday

Webinar Time:

   03:30 pm - 04:30 pm (Melbourne)
  05:30 pm - 06:30 pm (New Zealand)
  01:30 pm - 02:30 pm (Singapore)
  09:30 am - 10:30 am (Dubai)
  12:00 pm - 01:00 pm (Delhi)
  07:30 am - 08:30 am (South Africa/CEST)
Speaker
Natalia Carvajal

Natalia Carvajal
Technical Applications Scientist
Illumina Inc.

Natalia graduated from RMIT University, Australia in 2017 with a Master of Biotechnology. She gained experience in genomics and NGS-technologies in both clinical and academic settings from her time at the Peter MacCallum Cancer Centre and Monash University. Natalia joined Illumina as a Technical Applications Scientist in November 2023 and her main role is to support customers on Illumina’s instrumentation, library prep, microarray and clinical products.

 

Date & Time
Jul 30, 2025
Location
Affiliation
Illumina Inc.
Presenter
Natalia Carvajal,
Technical Applications Scientist
Register
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.